RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinoma
Our data suggested that RBM15 is critical in LUAD progression, is associated with tumor immune infiltration and served as a valuable potential diagnostic biomarker in patients.
Authors
- Qiubo Huang
- Li Li (ORCID: https://orcid.org/0000-0002-9702-4601)
- Xiaoyan Wang (ORCID: https://orcid.org/0000-0002-8229-0798)
- Wei Wang (ORCID: https://orcid.org/0000-0001-7656-0782)
- Chen Zhou (ORCID: https://orcid.org/0009-0000-5713-0074)
- Lianhua Ye (ORCID: https://orcid.org/0000-0002-7748-5830)
- Mingsheng Ma
Institutions
- Hubei University of Medicine (CN)
- Kunming Medical University (CN)
- Taihe Hospital (CN)
- Sixth Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1186/s13019-025-03585-6
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Kunming Medical University